Mumbai-based Sun Pharmaceutical Industries Ltd (Sun Pharma) plans to strengthen its presence in Europe and on the US generic drugs market following recent acquisitions in both these regions. Sun Pharma is to carry out developments and capacity expansions, as well as, possibly, to introduce new products developed by the company. The Hungarian subsidiary ICN Alkaloida Chemical RT is in Tiszavasvár, Szabolcs County and is one of the very few factories in the world authorized to make medicine agents. Its morphine output is 30% of that in Europe. Alkaloida has been producing considerable amounts of various organic and synthetic medicine agents. The Indian mother company is to expand and develop the research center currently hosting 450 researchers as well as restart the R&D laboratory. (Fri Vg 16) K.H.